# K253915: MOVIVA® Hybrid Ablation Probe

- Pathway: 510(k) (Traditional)
- Applicant: Erbe Elektromedizin GmbH
- Decided: Dec 18, 2025 after 10 days
- Product code: GEI (Electrosurgical, Cutting & Coagulation & Accessories)
- Device class: 2
- Regulation: 21 CFR 878.4400
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K952726 (1995). 31 ancestors in all.
No later device cites it as a predicate yet.
0 of 32 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K243120: HybridAPC probe, Erbe Elektromedizin GmbH (2025) Summary page 5.

## Indications for use
MOVIVA is intended for: • argon plasma coagulation and ablation of the mucosa, with or without lesions. • needle-free injection and tissue-selective hydrodissection including lifting mucosa by injection into the submucosa. MOVIVA is indicated for use in endoscopic procedures.

Source page: https://510kreport.com/device/K253915
Methodology: https://510kreport.com/methodology